Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
1. The spectrum of infectious diseases
1.2. 1. Hepatitis A;E
1.2. 2. Hepatitis C
1.2. 3. Hepatitis B, D
1.3. Herpes Zoster infections
1.4 HIV infections
1.4. TB and atypical mycobacterias
1.5. Bacterial infections
1.6 Non-mycobacterial opportunistic diseases
2. Comorbidities in patients with rheumatic disease
3. Drugs used in rheumatic disease
4. Risk/benefit management in the infectious phase.
5. Vaccine recommedations in patients with systemic rheumatic diseases
6. Education for patients/family and doctors
Infections in Systemic Autoimmune Diseases: Risk Factors and Management, Volume Sixteen describes the state-of-the-art of the risk factors and management treating the most common systemic autoimmune diseases (SADS). This updated volume consists of an introductory chapter that provides a brief overview of what different types of infectious diseases exist, followed by eight chapters detailing risk factors, guidelines and recommendations per different disease and bacterial infections. International in scope, the list of more than 20 contributors from Europa and America reads like a who’s who of clinical researchers in the field.
- Written by leading international clinical/surgical and scientific experts on Infection problems in systemic autoimmune diseases
- Provides a practical guide to the safer treatment of infections in patients with autoimmune diseases
- Includes a number of problems and recommendation that cannot be found in other books
- Designed as a ‘guide to clinical practice’ for management and risk interventions required by patients with SAD’s
Immunologists, rheumatologists, hematologists, cardiologists, postgraduate students and those working in autoimmune diseases, general medicine and hospital/pharmaceutical management
- No. of pages:
- © Elsevier 2020
- 8th March 2020
- eBook ISBN:
- Paperback ISBN:
"This is a short yet comprehensive book describing infections in systemic autoimmune diseases. This series, with over 30 contributors and 15 predecessor volumes to this 16th volume, collectively presents a comprehensive resource for
rheumatologists, clinical immunologists, infectious disease specialists, and internists who are searching for updates on the subject." --Doody
Fabiola Atzeni is currently a Specialist in Rheumatology and Ph.D. in Experimental Immunology by the University of Barcelona. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has (co)authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals Arthritis Research Therapy, Journal of Rheumatology and PlosOne, Lupus, Clinical Experimental. She is involved in several (international/national) meetings focused on cardiovascular and infection aspects in rheumatic disease
Specialist in Rheumatology, Experimental Immunology, University of Barcelona, Barcelona, Catalonia, Spain
Massimo is Doctor of medicine at the University of Milan. And director of the department of infectious diseases
Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan/UNIMI, Milan, Italy
Professor Juan Jose Gomez Reino MD is head of the rheumatology department at the University of Santiago. Juan obtained his MD and PhD from the Autonomous University of Madrid, he undertook his post doc training at the New York State University , Stony Brook USA. His clinical research mainly focuses on the search for improved treatments for Rheumatoid Arthrosis and Atherosclerosis which has resulted in many clinical treatment solutions.
Complejo Hospitalario Universitario de Santiago, Servicio de Reumatología, Travesia da Choupana, Santiago de Compostela, 15706, SPAIN
Dr Galloway is a clinical lecturer at King's College London and an honorary consultant in rheumatology at King's College Hospital. He runs the biologics assessment service for the rheumatology department. His research background has been in the study of biologic therapy safety. Within his role for KCL he works in the CRC accredited King's Clinical Trials Unit which has a large portfolio of investigator led trials. He also runs a phase 1 clinic in collaboration with the BRC facility and the Quintiles MHRA accredited Early Phase clinical trials unit at Guy's Hospital.
Kings College, London, UK
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.